Syros Pharmaceuticals, Inc. (SYRS) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2024-12-04

Syros Pharmaceuticals, Inc. (SYRS) — no SEC Form 4 insider filings recorded in the last 90 days. InsiderAlpha tracks every SYRS SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About Syros Pharmaceuticals, Inc. (SYRS)

SEC CIK0001556263

Recent SYRS Insider Transactions (Form 4)

DateInsiderRoleTransactionSharesPriceValueFiling
Simonian Nancy AInsiderS — Open-market sale37.1K$0.27$10KSEC
Simonian Nancy AInsiderS — Open-market sale134.7K$0.27$36KSEC
Quirk Gerald EChief Legal & Compliance OfficS — Open-market sale46.7K$0.22$10KSEC
Stephens KristinChief Development OfficerS — Open-market sale36.1K$0.22$8KSEC
Roth DavidChief Medical OfficerS — Open-market sale12.1K$0.20$2KSEC
Chee ConleyPresident & CEOS — Open-market sale134.8K$0.20$27KSEC
Haas JasonChief Financial OfficerS — Open-market sale137.8K$0.21$29KSEC
Haas JasonChief Financial OfficerF — Tax withholding / forfeiture5.6K$2.09$12KSEC
Stephens KristinChief Development OfficerM — Option exercise17.0K——SEC
Stephens KristinChief Development OfficerF — Tax withholding / forfeiture6.1K$2.09$13KSEC
Roth DavidChief Medical OfficerM — Option exercise18.9K——SEC
Roth DavidChief Medical OfficerF — Tax withholding / forfeiture6.8K$2.09$14KSEC
Simonian Nancy AInsiderM — Option exercise40.1K——SEC
Chee ConleyPresident & CEOF — Tax withholding / forfeiture8.7K$2.09$18KSEC
Haas JasonChief Financial OfficerM — Option exercise18.9K——SEC

All transactions sourced from SEC EDGAR Form 4 filings for Syros Pharmaceuticals, Inc. (SYRS). Updated in real time as new filings are submitted to the SEC.

Recent Insider Filings

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in SYRS insider filings:

POpen-market purchase by the insider
SOpen-market sale by the insider
AGrant, award, or other acquisition from the issuer
MExercise or conversion of derivative security (e.g. options)
FPayment of exercise price or tax liability via share withholding
GBona-fide gift of securities
DDisposition to the issuer (e.g. share buyback participation)
JOther acquisition or disposition
XExercise of in-the-money or at-the-money derivative security
CConversion of derivative security
VTransaction voluntarily reported earlier than required

SYRS Insider Trading — FAQ

What is the latest insider trade for SYRS?
Syros Pharmaceuticals, Inc. (SYRS) had 0 insider filings in the last 90 days, with the most recent on 2024-12-04. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying SYRS stock?
0 insider purchases of SYRS were filed in the last 90 days.
How many insiders are selling SYRS stock?
0 insider sales of SYRS were filed in the last 90 days.
Where can I see SYRS SEC filings (Form 4, 10-K, 10-Q, 8-K)?
InsiderAlpha aggregates every SYRS SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live SYRS dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.